These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19595465)

  • 1. Selective antagonism of anticancer drugs for side-effect removal.
    Fernández A; Sessel S
    Trends Pharmacol Sci; 2009 Aug; 30(8):403-10. PubMed ID: 19595465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The signal transduction pathway of multi-target kinase inhibitors as anticancer agents in clinical use or in phase III].
    Wu W; Lu C; Chen SY; Yu NF
    Yao Xue Xue Bao; 2009 Mar; 44(3):242-57. PubMed ID: 19449520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics.
    Cheng H; Force T
    Circ Res; 2010 Jan; 106(1):21-34. PubMed ID: 20056943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of drug inhibition of signalling molecules.
    Sebolt-Leopold JS; English JM
    Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular targeted therapies for solid tumors: management of side effects.
    Grünwald V; Soltau J; Ivanyi P; Rentschler J; Reuter C; Drevs J
    Onkologie; 2009 Mar; 32(3):129-38. PubMed ID: 19295254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New frontiers in cancer treatment].
    Tortora G; Daniele G
    Recenti Prog Med; 2006 Dec; 97(12):781-6. PubMed ID: 17252737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].
    Lang A; Graeven U
    Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug target interaction of tubulin-binding drugs in cancer therapy.
    Sengupta S; Thomas SA
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1433-47. PubMed ID: 17069528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multitargeted therapy: can promiscuity be praised in an era of political correctness?
    Jimeno A; Hidalgo M
    Crit Rev Oncol Hematol; 2006 Aug; 59(2):150-8. PubMed ID: 16843676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted cancer therapeutics.
    Hait WN; Hambley TW
    Cancer Res; 2009 Feb; 69(4):1263-7; discussion 1267. PubMed ID: 19208830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting transcription factors for cancer therapy.
    Frank DA
    IDrugs; 2009 Jan; 12(1):29-33. PubMed ID: 19127502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades.
    Bidwell GL; Raucher D
    Expert Opin Drug Deliv; 2009 Oct; 6(10):1033-47. PubMed ID: 19637980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a case for selectively promiscuous anticancer drugs?
    Fernández A; Crespo A; Tiwari A
    Drug Discov Today; 2009 Jan; 14(1-2):1-5. PubMed ID: 19038361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic effect of proliferation signal inhibitors: from biology to clinical application.
    Bertoni E; Salvadori M
    J Nephrol; 2009; 22(4):457-62. PubMed ID: 19662600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Target selectivity of anticancer drugs].
    Fattoruso SI; Di Lauro L; Conti F; Amodio A; Lopez M
    Clin Ter; 2008; 159(3):189-206. PubMed ID: 18594750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taming the induced folding of drug-targeted kinases.
    Fernández A; Bazán S; Chen J
    Trends Pharmacol Sci; 2009 Feb; 30(2):66-71. PubMed ID: 19097649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Front-line drug discovery system for cancer].
    Mizukami T
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2293-300. PubMed ID: 19098393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase inhibitor-induced endothelial cell cytotoxicity and its prediction based on calculated molecular descriptors.
    Herczenik E; Varga Z; Eros D; Makó V; Oroszlán M; Rugonfalvi-Kiss S; Romics L; Füst G; Kéri G; Orfi L; Cervenak L
    J Recept Signal Transduct Res; 2009; 29(2):75-83. PubMed ID: 19519173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C as a therapeutic target.
    Teicher BA
    Clin Cancer Res; 2006 Sep; 12(18):5336-45. PubMed ID: 17000666
    [No Abstract]   [Full Text] [Related]  

  • 20. Translation initiation: a critical signalling node in cancer.
    Robert F; Pelletier J
    Expert Opin Ther Targets; 2009 Nov; 13(11):1279-93. PubMed ID: 19705976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.